Literature DB >> 1576145

Pediatric heart transplantation for doxorubicin-induced cardiomyopathy.

R P McManus1, D P O'Hair.   

Abstract

The prognosis of patients with a history of successfully treated malignancy, who subsequently undergo organ transplantation and long-term immunosuppression, is uncertain. We report the case of a 14-year-old girl in whom doxorubicin-induced cardiomyopathy developed after aggressive therapy for a fibroblastic osteosarcoma. The patient underwent orthotopic heart transplantation and remains in remission 14 months after surgery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576145

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

Review 1.  Heart transplantation in survivors of childhood cancer.

Authors:  Svetlana B Shugh; Thomas D Ryan
Journal:  Transl Pediatr       Date:  2019-10

2.  Aggressive management of doxorubicin-induced cardiomyopathy associated with 'low' doses of doxorubicin.

Authors:  S Sriskandan; M E O'Brien; I E Smith; P Collins; M E Gore
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

3.  Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia.

Authors:  John M Goldberg; Rebecca E Scully; Stephen E Sallan; Steven E Lipshultz
Journal:  J Pediatr Hematol Oncol       Date:  2012-07       Impact factor: 1.289

Review 4.  Current State of Pediatric Cardio-Oncology: A Review.

Authors:  Molly Brickler; Alexander Raskin; Thomas D Ryan
Journal:  Children (Basel)       Date:  2022-01-19

Review 5.  Orthotopic Heart Transplantation and Mechanical Circulatory Support in Cancer Survivors: Challenges and Outcomes.

Authors:  Nina Ghosh; John Hilton
Journal:  J Oncol       Date:  2015-08-03       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.